€60.00
Semaglutide is a GLP-1 receptor agonist peptide with a molecular weight of approximately 4,113.58 Da. Each vial contains 10mg of lyophilised semaglutide (>98% purity by HPLC), manufactured under research-grade conditions with a manufacturer COA. Supplied as a sterile lyophilised powder. Requires reconstitution with bacteriostatic water prior to use. Store the lyophilised peptide at -20°C for long-term storage. For short periods it stays stable refrigerated (2-8°C) or at room temperature, so ambient shipping does not compromise it. Once reconstituted, keep the solution at 2-8°C and use within 28 days. Intended for research purposes only. Not for human use.
Sema + Cagri – GLP-1 Plus For Sale
This vial contains a 1:1 blend of Sema (a GLP-1 agonist) and Cagri (an amylin analogue). This combination is often used in scientific research to analyze dual hormonal pathways in energy expenditure, satiety signaling, and metabolic control.
Chemical profile
This product is a high-purity (>99%) lyophilized (freeze-dried) powder that requires reconstitution. It is intended for laboratory processing and experimental analysis only.
-
Ingredient 1: Semaglutide (GLP-1 receptor agonist)
-
Ingredient 2: Cagrilintide (long-acting amylin analogue)
-
Total amount: [10 mg]
-
Purity: >99% (Determined by HPLC)
Quality assurance
-
HPLC analysis: Confirmed purity >99%.
-
Mass spectrometry: Confirmed molecular weight and structure.
-
Toxicity: Not tested for human safety.
Research Context (Literature Review) Sema + Cagri – GLP-1 Plus
Note: The following information is for educational purposes regarding the chemical properties of these peptides and does not constitute a medical claim.
This combination allows researchers to analyze the co-activation of two distinct nutrient response systems. Semaglutide acts on the GLP-1 receptor, modulating insulin and glucagon. Cagrilintide is a stable analogue of amylin, a hormone secreted with insulin that delays gastric emptying and induces satiety via amylin receptors in the midbrain.
Current laboratory studies are exploring the synergistic potential of this combination. Animal models suggest that simultaneous activation of the GLP-1 and amylin pathways results in greater weight loss and improved glycemic control compared to administration of either peptide alone.
Technical specifications Sema + Cagri – GLP-1 Plus
| Specification | Data |
| CAS number (Semaglutide) | 910463-68-2 |
| CAS Number (Kagrylintid) | 1415456-99-3 |
| Molecular formula | $C_{187}H_{291}N_{45}O_{59}$ (Sema) / $C_{148}H_{224}N_{38}O_{40}$ (Cagri) |
| Molecular mass | 4113.6 g/mol (Sema) / 3415.9 g/mol (Cagri) |
| Appearance | White to off-white lyophilized powder |
| Solubility | Soluble in bacteriostatic water or sterile water |
| Storage (lyophilized) | Store at -20°C (freezer). Stable for up to 24 months. |
| Storage (after reconstitution) | Store at +4°C (refrigerator). Use within 4 weeks. |
| Dosage | 5mg – 5mg |
|---|
Be the first to review “Sema + Cagri – GLP-1 Plus”
Related products
Peptides
Peptides
Peptides
Peptides
Peptides
Peptides
Peptides
Peptides
Reviews
There are no reviews yet.